Marshall Wace’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.7M Buy
1,080,669
+1,049,104
+3,324% +$24.7M 0.02% 587
2026
Q1
$472K Sell
31,565
-1,401,916
-98% -$23.9M ﹤0.01% 2479
2025
Q4
$20.9M Sell
1,433,481
-22,505
-2% -$392K 0.02% 618
2025
Q3
$26.1M Sell
1,455,986
-1,642,751
-53% -$24.1M 0.03% 545
2025
Q2
$52.9M Buy
3,098,737
+2,498,186
+416% +$25M 0.06% 281
2025
Q1
$4.35M Sell
600,551
-888,710
-60% -$10.1M 0.01% 1129
2024
Q4
$20.9M Buy
1,489,261
+1,042,587
+233% +$15.4M 0.03% 525
2024
Q3
$5.3M Buy
446,674
+1,691
+0.4% +$17.5K 0.01% 979
2024
Q2
$4.14M Buy
444,983
+329,385
+285% +$1.68M 0.01% 1081
2024
Q1
$409K Buy
+115,598
New +$401K ﹤0.01% 2009

Other funds holding CORZ

Marshall Wace's CORZ Position: Q2 2026 in Review

Marshall Wace increased its Core Scientific (CORZ) stake by 3,324% in Q2 2026, buying an estimated $24.7M and bringing the position to 1,080,669 shares worth $27.7M. The position accounts for 0.02% of the portfolio, ranked #587.

Marshall Wace first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $52.9M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Marshall Wace held 1,080,669 shares of Core Scientific worth $27.7M as of Q2 2026.
  • Marshall Wace bought 1,049,104 Core Scientific shares in Q2 2026, an estimated $24.7M.
  • Core Scientific made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #587 holding.
  • Marshall Wace first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Marshall Wace's Core Scientific position peaked at $52.9M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.